Palisade Bio Investor Relations Material
Latest events
Q1 2025
2 Jun, 2025
Q4 2024
24 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Palisade Bio Inc
Access all reports
Palisade Bio Inc is a U.S.-based clinical-stage biopharmaceutical company developing therapeutics for gastrointestinal health. The company focuses on reducing post-surgical complications and improving recovery outcomes through targeted enzyme inhibitors. It collaborates with research institutions and conducts clinical trials to advance its drug candidates. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
PALI
Country
🇺🇸 United States